🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07082101
Starting soon Not applicable

Temporal Interference for Temporal Lobe Epilepsy Under SEEG

NCT07082101 · tracked via the Priya Life Science China tracker
Sponsor
Xijing Hospital
Phase
Not applicable
Started
2025-08-15
Last updated
2025-07-24

Condition(s) studied

Epilepsy

Investigational drug(s) / intervention(s)

temporal interference

temporal interference: In this intervertion, patients with SEEG operation will take temporal interference (TI) stimulation and the deep brain EEG will be monitorated through the entire experiment.

Study summary

This study evaluates the effect of temporal interference (TI) stimulation on biomarkers in patients with temporal lobe epilepsy (TLE) under stereo-electroencephalography (SEEG), and provides theoretical basis for non-invasive TI treatment of temporal lobe epilepsy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Clinical diagnosis of drug refractory epilepsy and temporal lobe epilepsy; * Patients undergoing SEEG; * Able to cooperate the treatment and related inspection; * Fully understands and signs informed consent. Exclusion Criteria: * Patients with temporal plus epilepsy; * In status epilepticus; * With other severe disease; * Pregnancy or lactation women; * Unable to tolerate SEEG or TI; * At the same time to participate in other clinical trials; * Withdraw consent procedure.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Xijing Hospital Xi'an Shaanxi

More Xijing Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07082101 on ClinicalTrials.gov ↗ ← All trials in China